Bonilla-Moreno Raúl, Pérez-Yépez Eloy-Andrés, Villegas-Sepúlveda Nicolás, Morales Fernando O, Meza Isaura
Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Apartado 14-740, México City 07360, Mexico.
Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Apartado 14-740, México City 07360, Mexico.
Mol Biochem Parasitol. 2016 Aug;208(2):49-55. doi: 10.1016/j.molbiopara.2016.05.014. Epub 2016 Jun 16.
Entamoeba histolytica trophozoites dwell in the human intestine as comensals although under still unclear circumstances become invasive and destroy the host tissues. For these activities, trophozoites relay on remarkable motility provided by the cytoskeleton organization. Amebic actin and some of its actin-associated proteins are well known, while components of the myosin II molecule, although predicted from the E. histolytica genome, need biochemical and functional characterization. Recently, an amebic essential light myosin II chain, named EhMLCI, was identified and reported to be phosphorylated in tyrosines. The phosphorylated form of the protein was associated with the soluble assembly incompetent conformation of the heavy myosin chains, while the non-phosphorylated protein was identified with filamentous heavy chains, organized in an assembly competent conformation. It was postulated that EhMLCI tyrosine phosphorylation could act as a negative regulator of myosin II activity by its phosphorylation/dephosphorylation cycles. To test this hypothesis, we constructed an expression vector containing an EhMLCI DNA sequence where two tyrosine residues, with strong probability of phosphorylation and fall within the single EF-hand domain that interacts with the N-terminus of myosin II heavy chains, were replaced by phenylalanines. Transfected trophozoites, expressing the mutant MutEhMLCI protein cannot process it, thereby not incorporated into the phosphorylation/dephosphorylation cycles required for myosin II activity, results in motility defective trophozoites.
溶组织内阿米巴滋养体作为共生体寄居于人体肠道,但在尚不清楚的情况下会变得具有侵袭性并破坏宿主组织。对于这些活动,滋养体依赖于细胞骨架组织提供的显著运动能力。阿米巴肌动蛋白及其一些肌动蛋白相关蛋白是众所周知的,而肌球蛋白II分子的组成部分,尽管从溶组织内阿米巴基因组中已被预测,但仍需要进行生化和功能表征。最近,一种名为EhMLCI的阿米巴必需轻肌球蛋白II链被鉴定出来,并据报道其酪氨酸发生了磷酸化。该蛋白的磷酸化形式与重肌球蛋白链的可溶性组装无能力构象相关,而非磷酸化蛋白则与丝状重链相关,以组装有能力的构象组织。据推测,EhMLCI酪氨酸磷酸化可能通过其磷酸化/去磷酸化循环作为肌球蛋白II活性的负调节因子。为了验证这一假设,我们构建了一个表达载体,其中包含一个EhMLCI DNA序列,在该序列中,两个具有高磷酸化可能性且位于与肌球蛋白II重链N端相互作用的单个EF-手结构域内的酪氨酸残基被苯丙氨酸取代。表达突变型MutEhMLCI蛋白的转染滋养体无法对其进行加工,因此无法纳入肌球蛋白II活性所需的磷酸化/去磷酸化循环,导致滋养体运动缺陷。